The Alazami Syndrome-Associated Protein LARP7 Guides U6 Small Nuclear RNA Modification and Contributes to Splicing Robustness.
Alternative Splicing
Binding Sites
Cell Line, Tumor
Child
Child, Preschool
Conserved Sequence
Developmental Disabilities
/ genetics
Female
Genetic Predisposition to Disease
HEK293 Cells
Humans
Male
Methylation
Middle Aged
Mutation
Nucleic Acid Conformation
Protein Binding
Protein Interaction Domains and Motifs
RNA, Small Nuclear
/ genetics
Ribonucleoproteins
/ genetics
Spliceosomes
/ genetics
2′-O-methylation
Alazami syndrome
LARP7
RNA binding proteins
U6 snRNA
snRNAs
snoRNAs
splicing
Journal
Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571
Informations de publication
Date de publication:
05 03 2020
05 03 2020
Historique:
received:
15
07
2019
revised:
25
11
2019
accepted:
26
12
2019
pubmed:
6
2
2020
medline:
7
7
2020
entrez:
5
2
2020
Statut:
ppublish
Résumé
The La-related protein 7 (LARP7) forms a complex with the nuclear 7SK RNA to regulate RNA polymerase II transcription. It has been implicated in cancer and the Alazami syndrome, a severe developmental disorder. Here, we report a so far unknown role of this protein in RNA modification. We show that LARP7 physically connects the spliceosomal U6 small nuclear RNA (snRNA) with a distinct subset of box C/D small nucleolar RNAs (snoRNAs) guiding U6 2'-O-methylation. Consistently, these modifications are severely compromised in the absence of LARP7. Although general splicing remains largely unaffected, transcriptome-wide analysis revealed perturbations in alternative splicing in LARP7-depleted cells. Importantly, we identified defects in 2'-O-methylation of the U6 snRNA in Alazami syndrome siblings carrying a LARP7 mutation. Our data identify LARP7 as a bridging factor for snoRNA-guided modification of the U6 snRNA and suggest that alterations in splicing fidelity contribute to the etiology of the Alazami syndrome.
Identifiants
pubmed: 32017898
pii: S1097-2765(20)30001-0
doi: 10.1016/j.molcel.2020.01.001
pii:
doi:
Substances chimiques
Larp7 protein, human
0
RNA, Small Nuclear
0
Ribonucleoproteins
0
U6 small nuclear RNA
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1014-1031.e13Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Interests The authors declare no competing interests.